Concepedia

Author

Xianjun Cao

Pfizer (United States)

Also Known As

Xianjun Cao

12

Publications

237

Citations

6

H-Index

27

Concepts

All Affiliations

Pfizer (United States)Biogen (United States)Center for Innovation
XC

About

Xianjun Cao is an author at Pfizer (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

122

2

Cell Biology

3

3

122

3

Immunology

2

2

91

4

Health Sciences

1

1

31

5

Biochemistry

1

1

31

Xianjun Cao

×

6

Publications

224

Citations

6

H-Index

YearCitations

Requirement of Tyrosine- and Serine/Threonine Kinases in the Transcriptional Activation of the Mammalian grp78/BiP Promoter by Thapsigargin

Xianjun Cao, Yanhong Zhou, Amy S. Lee

Journal of Biological Chemistry

1995

57

In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain

Takehiko Nakamura, William S. Kloetzer, Peter Brams,

International Journal of Immunopharmacology

2000

48

Novel Anti-TM4SF1 Antibody–Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature

Alberto Visintin, Kelly M. Knowlton, Edyta Tyminski,

Molecular Cancer Therapeutics

2015

43

Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption

Kristen Johnson, Kymberly K. Levine, Joseph A. Sergi,

Journal of Bone and Mineral Research

2017

31

Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties

Adam Doern, Xianjun Cao, Arlene Sereno,

Journal of Biological Chemistry

2009

26

An Intermediate pH Unfolding Transition Abrogates the Ability of IgE to Interact with Its High Affinity Receptor FcϵRIα

Stephen J. Demarest, Jennifer Hopp, Julie Chung,

Journal of Biological Chemistry

2006

19

Page 1